Site Home   Gender and Dementia       Introduction to Gender and Health   The Gender Lens Tool

References for this Section

1. Hanon O, Forette F. Treatment of hypertension and prevention of dementia. Alzheimer's and Dementia 2005; 1:30-7.

2. Sheppard JE. Effects of cognition, mood and degenerative brain diseases. J Am Pharm Assoc 2001; 41(2):221-8.

3. Espeland MA, Rapp SR, Shumaker SA Brunner R, Manson JE, Sherwin, BB et al. Conjugated equine estrogens and global cognitive function in postmenopausal women: Women's Health Initiative Memory Study. JAMA 2004; 291:2959-68.

4. Isbir T, Agachan B, Yilmaz, H, Aydin M, Kara, I Eker E, Eker D. Apolipoprotein-E gene polymorphism and lipid profiles in Alzheimer's disease. Am J Alzheimers Dis Other Demen 2001; 16:77-81.

5. Kearney PM, Whelton M, Reynolds N et al. Global burden of hypertension: analysis of worldwide data. Lancet 2005; 365(9455):217-23.

6. Sowers, JR. Diabetes in elderly and in women: cardiovascular risks. Cardiol Clin 2004; 22:541-51.

7. Gustafson D, Lissner L, Begtsson C, Bjorkelund C, Skoog I. A 24-year follow-up of body mass index and cerebral atrophy. Neurology 2004; 63:1876-81.

8. Seshadri S, Wolf PA. Homocysteine and the brain: vascular risk factor or neurotoxin? Lancet Neurology Jan; 2(1):11.

9. Qui C, von Strauss E, Fastbom J, Winbald B, Fratiglioni L. Low blood pressure and risk of dementia in the Kungsholmen project: a 6-year follow up study. Arch Neurol 2003; 60(2):223-8.

10. van Duijin CM, Clayton D et al. Familial aggression of Alzheimer's disease and related disorders: a collaborative re-analysis of case-control studies. International Journal of Epidemilogy. 1991; 20(2):S13.

11. Slooter AJ, Cruts M, Hofman A, Koudstaal PJ, van der Kuip D, de Ridder MA et al. The impact of APOE on myocardial infarction, stroke and dementia: the Rotterdam Study. Neurology 2004; 62:1196-8.